A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevitySven J. van der Lee, Estrella Morenas‐Rodríguez, The GIFT (Genetic Investigation in Frontotemporal Dementia and Alzheimer’s Disease) Study Group et al.|Acta Neuropathologica|2019Cited by 132
Resilience and resistance to the accumulation of amyloid plaques and neurofibrillary tangles in centenarians: An age‐continuous perspectiveMeng Zhang, Henne Holstege, Andrea B. Ganz et al.|Alzheimer s & Dementia|2022Cited by 43